Han et al. found that miR-138 inhibited the proliferation, migration, and invasion of non-small-cell lung cancer cells and increased the sensitivity to chemotherapy by directly targeting CCND3 16, indicating that a reduction in CCND3 increases the sensitivity of non-small-cell lung cancer cells to DDP. Here, CCND3 is linked to non-small cell lung carcinoma.